JP2014534266A5 - - Google Patents

Download PDF

Info

Publication number
JP2014534266A5
JP2014534266A5 JP2014543634A JP2014543634A JP2014534266A5 JP 2014534266 A5 JP2014534266 A5 JP 2014534266A5 JP 2014543634 A JP2014543634 A JP 2014543634A JP 2014543634 A JP2014543634 A JP 2014543634A JP 2014534266 A5 JP2014534266 A5 JP 2014534266A5
Authority
JP
Japan
Prior art keywords
tsgl
polypeptide
molecule
seq
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014543634A
Other languages
English (en)
Japanese (ja)
Other versions
JP6181066B2 (ja
JP2014534266A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/066910 external-priority patent/WO2013082200A1/en
Publication of JP2014534266A publication Critical patent/JP2014534266A/ja
Publication of JP2014534266A5 publication Critical patent/JP2014534266A5/ja
Application granted granted Critical
Publication of JP6181066B2 publication Critical patent/JP6181066B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014543634A 2011-11-28 2012-11-28 新規な増強型セレクチンアンタゴニスト Active JP6181066B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161564275P 2011-11-28 2011-11-28
US61/564,275 2011-11-28
PCT/US2012/066910 WO2013082200A1 (en) 2011-11-28 2012-11-28 Novel enhanced selectin antagonists

Publications (3)

Publication Number Publication Date
JP2014534266A JP2014534266A (ja) 2014-12-18
JP2014534266A5 true JP2014534266A5 (enExample) 2015-12-24
JP6181066B2 JP6181066B2 (ja) 2017-08-16

Family

ID=48467086

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014543634A Active JP6181066B2 (ja) 2011-11-28 2012-11-28 新規な増強型セレクチンアンタゴニスト

Country Status (5)

Country Link
US (1) US8889628B2 (enExample)
EP (1) EP2785843B1 (enExample)
JP (1) JP6181066B2 (enExample)
CA (1) CA2857019C (enExample)
WO (1) WO2013082200A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2914470C (en) 2013-06-03 2022-09-27 Emory University Selectin inhibitors, composition, and uses related thereto
KR20250159733A (ko) 2017-01-11 2025-11-11 브리스톨-마이어스 스큅 컴퍼니 Psgl-1 길항제 및 그의 용도
PE20250933A1 (es) 2017-03-14 2025-04-02 Five Prime Therapeutics Inc Anticuerpos de union a vista a ph acido
US12479904B2 (en) 2017-12-29 2025-11-25 Gray D Shaw Methods of treating cytokine release syndrome by administering a molecule comprising a soluble tandem selectin glycoprotein ligand
SG11202008593PA (en) 2018-03-21 2020-10-29 Five Prime Therapeutics Inc ANTIBODIES BINDING TO VISTA AT ACIDIC pH
AU2019301120A1 (en) 2018-07-11 2021-02-25 Bristol-Myers Squibb Company Antibodies binding to VISTA at acidic pH
US20230303657A1 (en) * 2020-03-10 2023-09-28 Gray D Shaw Fusion Molecules of PSGL-1 or TSGL Anionic Domains to Checkpoint-Modulating Antibodies and Other Antibodies
WO2023049265A1 (en) * 2021-09-23 2023-03-30 Beth Israel Deaconess Medical Center, Inc. P-selectin inhibitors and uses thereof
WO2026080432A1 (en) * 2024-10-07 2026-04-16 Beth Israel Deaconess Medical Center, Inc. Dimeric p-selectin inhibitors and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277975B1 (en) * 1992-10-23 2001-08-21 Genetics Institute, Inc. Fusions of P-selectin ligand protein and polynucleotides encoding same
WO2000065068A1 (en) * 1999-04-23 2000-11-02 Ceptyr, Inc. Dsp-10 dual-specificity map kinsase phosphatase
NZ521687A (en) * 2000-03-31 2004-11-26 Inst Genetics Llc Modulating, e.g., preventing, inhibiting or treating thrombosis, comprising administering a P-selectin antagonist to subject with cardiovascular disorder such as atherosclerosis or hypertension
US20040086519A1 (en) * 2000-09-12 2004-05-06 Genetics Institute, Llc Inhibition of stenosis or restenosis by P-selectin ligand antagonists
CA2457400A1 (en) * 2001-08-03 2003-02-20 Genetics Institute, Llc Modulation of leukocyte-endothelial interactions following ischemia
CA2622772A1 (en) * 2005-09-29 2007-04-12 Viral Logic Systems Technology Corp. Immunomodulatory compositions and uses therefor
DK3178835T3 (da) * 2009-02-03 2019-06-24 Amunix Pharmaceuticals Inc Forlængede rekombinante polypeptider og sammensætninger omfattende samme

Similar Documents

Publication Publication Date Title
JP2016000731A5 (enExample)
JP2012522529A5 (enExample)
PE20221909A1 (es) Moleculas de union a antigeno que comprenden un trimero de ligando de la familia de tnf
JP2012082206A5 (enExample)
JP2015524403A5 (enExample)
RU2015152077A (ru) Тримерные антигенсвязывающие молекулы
JP2012025737A5 (enExample)
JP2012025766A5 (enExample)
JP2015525217A5 (enExample)
JP2010088434A5 (enExample)
FI3835310T3 (fi) Fibronektiinipohjaisia telinedomeeniproteiineja, jotka sitoutuvat myostatiiniin
EA201400568A1 (ru) Альбуминсвязывающие антитела и их связывающие фрагменты
JP2015212284A5 (enExample)
SI3191511T1 (en) Improved TNF binders
JP2016502512A5 (enExample)
RU2011138844A (ru) Композиции бендамустина и циклополисахарида
JP2015134758A5 (enExample)
AR071874A1 (es) Proteinas de dominio de armazon basadas en fibronectina multivalentes
HRP20250195T1 (hr) Anti-fcrn antitijela
JP2019527200A5 (enExample)
JP2014525735A5 (enExample)
JP2017512063A5 (enExample)
JP2013509879A5 (enExample)
JP2017509335A5 (enExample)
AR066311A1 (es) Moleculas de anticuerpos anti proteina hsp90 fungica y acidos nucleicos que los codifican